Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 1,563 across all filing types
Latest filing 2018-12-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
第三届董事会第十八会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by Zhejiang Huatong Pharmaceutical Co., Ltd. It details the convening of the board meeting, attendance, and the approval of a proposal regarding the use of raised funds by a subsidiary to purchase property. It includes voting results and references related announcements. The document is not a full report but a specific board decision announcement. It does not contain financial statements or detailed financial data, nor is it a general regulatory filing or a report publication announcement. The content fits best under 'Board/Management Information' (MANG) as it announces a board resolution and related management decisions.
2018-12-27 Chinese
华金证券股份有限公司关于公司全资子公司使用募集资金购买房产暨关联交易的核查意见
Regulatory Filings
2018-12-27 Chinese
独立董事关于全资子公司购买房产暨关联交易的事前认可意见
Board/Management Information Classification · 95% confidence The document is a pre-approval opinion from independent directors regarding a related-party transaction involving the purchase of property by a wholly-owned subsidiary using raised funds. It references regulatory guidelines for independent directors and related-party transactions. The content is a formal opinion on a specific transaction to be reviewed by the board, not a financial report, earnings release, or announcement of voting results. It is related to board/management oversight and governance of company transactions. Therefore, it fits best under Board/Management Information (MANG) as it concerns board-level approval and oversight of a significant transaction.
2018-12-27 Chinese
第三届监事会第十五会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a resolution passed at a supervisory board meeting of Zhejiang Huatong Pharmaceutical Co., Ltd. It details the meeting date, attendance, and the approval of a related-party transaction involving the use of raised funds to purchase property. The document includes voting results and references compliance with company law and articles of association. It also mentions a related announcement published elsewhere. The document is short (954 characters) and serves as a meeting resolution announcement rather than a full report or financial statement. It does not contain financial data, audit information, or detailed management discussion. It is not a regulatory filing or certification letter. The content fits best under Board/Management Information (MANG) as it relates to supervisory board decisions and governance matters.
2018-12-27 Chinese
关于“华通转债”开始转股的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the start of the conversion period for a convertible bond issued by Zhejiang Huatong Pharmaceutical Co., Ltd. It includes specifics about the bond issuance, conversion price, conversion period, terms for redemption and repurchase, and other related procedural details. The document is regulatory in nature, providing information about the convertible bond and its conversion process, but it is not a financial report, earnings release, or management discussion. It is also not a simple announcement of a report publication but a substantive disclosure about convertible bond terms and conditions. This fits best under the category of Capital/Financing Update (CAP), as it relates to the company's financing instruments and capital structure changes through convertible bonds.
2018-12-19 Chinese
关于股东股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding shareholder stock pledges related to a convertible bond issuance by Zhejiang Huatong Pharmaceutical Co., Ltd. It details the pledge of shares by major shareholders as collateral for the bond issuance, including specific numbers of shares pledged, pledge start and end dates, and the purpose of the pledge. The document does not contain financial statements, earnings data, or detailed financial analysis. It is a regulatory disclosure about share pledging activity, which is related to capital structure but specifically about shareholder share pledges as collateral. This fits best under Capital/Financing Update (CAP) as it updates on financing activities and capital structure changes related to share pledges for bond issuance. The document length is short and it is not a report publication announcement or a certification. Therefore, the appropriate classification is CAP with high confidence.
2018-11-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.